These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21542101)

  • 1. Perioperative rupture of the LIMA graft leading to cardiogenic shock, emergency angiography, and stenting with a polytetrafluoroethylene-covered stent.
    Yeow WL; Edwards M; Yong G
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):640-3. PubMed ID: 21542101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful deployment of polytetrafluoroethylene-covered stent to seal left internal mammary artery graft perforation due to guide catheter extension system.
    Ichimoto E; De Gregorio J
    Cardiovasc Revasc Med; 2016 Dec; 17(8):574-577. PubMed ID: 27394179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting.
    Barlis P; Horrigan M; Elis S; Chan R; Wong M; Farouque O; Proimos G; Ajani AE; Clark DJ
    Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation.
    Ovünç K; Yorgun H; Ozer N
    Cardiovasc Revasc Med; 2009; 10(4):252-4. PubMed ID: 19815173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
    Gioia G; Matthai W; Gillin K; Dralle J; Benassi A; Gioia MF; White J
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):26-33. PubMed ID: 17585381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual balloon rupture during direct stenting with a TaxusExpress stent in a venous graft complicated by vessel rupture: a device-related fatal event.
    Christiansen EH
    J Interv Cardiol; 2007 Feb; 20(1):23-5. PubMed ID: 17300393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iatrogenic left internal mammary artery-coronary vein anastomosis treated with covered stent deployment via retrograde percutaneous coronary sinus approach.
    Sheiban I; Moretti C; Colangelo S
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):704-7. PubMed ID: 17039511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unprotected left main stenting with a second-generation drug-eluting stent: one-year outcomes of the LEMAX Pilot study.
    Salvatella N; Morice MC; Darremont O; Tafflet M; Garot P; Leymarie JL; Chevalier B; Lefèvre T; Louvard Y; Boudou N; Dumonteil N; Carrié D
    EuroIntervention; 2011 Oct; 7(6):689-96. PubMed ID: 21986327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheolytic effects of left main mid-shaft/distal stenting: a computational flow dynamic analysis.
    Rigatelli G; Zuin M; Dell'Avvocata F; Nguyen T
    Ther Adv Cardiovasc Dis; 2018 Jun; 12(6):161-168. PubMed ID: 29589515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial.
    Blazek S; Rossbach C; Borger MA; Fuernau G; Desch S; Eitel I; Stiermaier T; Lurz P; Holzhey D; Schuler G; Mohr FW; Thiele H
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):30-8. PubMed ID: 25499302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atresia of the left internal mammary artery graft following percutaneous intervention of the left main.
    Kalaga R; Uretsky BF; Sachdeva R
    J Invasive Cardiol; 2011 Dec; 23(12):E284-7. PubMed ID: 22147410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting versus bare metal coronary stents: long-term human pathology. Findings from different coronary arteries in the same patient.
    Guagliumi G; Virmani R; Musumeci G; Motta T; Valsecchi O; Bonaldi G; Saino A; Tespili M; Greco N; Farb A
    Ital Heart J; 2003 Oct; 4(10):713-20. PubMed ID: 14664285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
    J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of rotational atherectomy in preventing polymer damage of everolimus-eluting stent in calcified coronary artery.
    Kuriyama N; Kobayashi Y; Yamaguchi M; Shibata Y
    JACC Cardiovasc Interv; 2011 May; 4(5):588-9. PubMed ID: 21596335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.